On June 24, 2024, the Department of Health and Human Services (“HHS”) released a final rule (“Disincentives Final Rule”) establishing disincentives for certain healthcare providers that have committed information blocking. The information blocking disincentives directly impact Medicare-enrolled healthcare providers or suppliers including hospitals, critical access hospitals, MIPS-eligible clinicians, and ACOs. The Disincentives Final Rule has been submitted to the Office of the Federal Register for publication and will become effective 30 days after Federal Register publication.

Information blocking occurs when a health care provider knowingly engages in a practice that unreasonably and likely interferes with, prevents, or materially discourages the access, exchange, or use of electronic health information, unless otherwise required by law or covered by an exception. Examples of information blockings include:

  • Contract limitations that restrict a physician’s use and exchange of medical information;
  • Charging excessive fees to create electronic health record (“EHR”) interfaces or connections with other information technology entities;
  • Using technical or non-standardized methods of implementing EHR and other health information technology that block the access, exchange, or use of medical information.

The Disincentives Final Rule was created pursuant to the 21st Century Cures Act, and established “disincentives” or negative conditions for health care providers that are found to be in violation as determined by an OIG investigation.

Health care providers subject to the Disincentives Final Rule must be Medicare-enrolled providers or suppliers. This rule goes hand-in-hand with the OIG’s June 2023 final rule that established civil monetary penalties of up to $1 million per violation against information blocking actors, but excluded healthcare providers. For more Crowell insights on that rule, see our prior client alert.

Upon an OIG finding that a health care provider has committed information blocking and referred the party to CMS, the health care provider is subject to three major disincentives:

  1. Certain hospitals will be ineligible for meaningful EHR user status.  The Medicare Promoting Interoperability (PI) Program establishes that eligible hospitals and critical access hospitals that engage in information blocking will be ineligible for annual market-based monetary increases granted to qualifying EHR users. Hospitals subject to this disincentive would be ineligible to earn the three quarters of the annual market basket increase associated with qualifying meaningful EHR users. Critical access hospitals will have its payment reduced from 101% to 100% of reasonable costs it might have otherwise earned in an applicable year.
  2. Merit-based Incentive Payment System (MIPS) eligible clinicians will not be meaningful EHR users. MIPS clinicians who have committed information blocking will not be considered meaningful EHR users and will receive a zero score in the MIPS Promoting Interoperability performance category. The score is typically a quarter of an individual MIPS eligible clinician’s total final score in a performance period/MIPS payment year, unless an exception applies and the MIPS eligible clinician is not required to report measures for the performance category. This disincentive applies only to the individual even if he or she reports as part of a group.
  3. Accountable care organization (“ACO”) participants, providers, or suppliers may be ineligible to participate in the Medicare Shared Savings Program (MSSP) for at least one year. ACO providers found to have committed information blocking may not receive revenue they would otherwise have earned through the Shared Savings Program. Before applying this disincentive, CMS will consider “relevant facts and circumstances” which include, but are not limited to the following:
    • the nature of the health care provider’s information blocking;
    • the health care provider’s diligence in identifying and correcting the problem;
    • the time since the information blocking occurred; and
    • whether the provider was found to be an information blocker previously.

Finally, HHS may establish additional disincentives through future rulemaking.

Key Takeaways

As we previously noted, the disincentives apply to health care providers that are eligible for enumerated programs but not, for example, pharmacists, pharmacies or laboratories that are actors under the ONC Information Blocking Rule but do not participate in the PI, MIPS or MSSP. Any appeals of the disincentives are only available under existing authorities of the appropriate agencies and are not specifically provided under the Cures Act for the OIG’s findings of information blocking. It is critical for impacted health care providers to assess their policies and practices against the information blocking requirements and develop (or verify the establishment of) organizational policies and practices to assure compliance with the information blocking rules and avoid violations.

For more information on how this Rule could impact your organization or for further guidance on how your organization can prepare for compliance, please contact our team.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of Jodi G. Daniel Jodi G. Daniel

Jodi Daniel is a partner in Crowell & Moring’s Health Care Group and a member of the group’s Steering Committee. She is also a director at C&M International (CMI), an international policy and regulatory affairs consulting firm affiliated with Crowell & Moring. She…

Jodi Daniel is a partner in Crowell & Moring’s Health Care Group and a member of the group’s Steering Committee. She is also a director at C&M International (CMI), an international policy and regulatory affairs consulting firm affiliated with Crowell & Moring. She leads the firm’s Digital Health Practice and provides strategic, legal, and policy advice to all types of health care and technology clients navigating the dynamic regulatory environment related to technology in the health care sector to help them achieve their business goals. Jodi is a contributor to the Uniform Law Commission Telehealth Committee, which drafts and proposes uniform state laws related to telehealth services, including the definition of telehealth, formation of the doctor-patient relationship via telehealth, creation of a registry for out-of-state physicians, insurance coverage and payment parity, and administrative barriers to entity formation.

Photo of Lidia Niecko-Najjum Lidia Niecko-Najjum

Lidia Niecko-Najjum is a counsel in Crowell & Moring’s Health Care Group and is part of the firm’s Digital Health Practice. With over 15 years of clinical, policy, and legal experience, Lidia provides strategic advice on health care regulatory and policy matters, with…

Lidia Niecko-Najjum is a counsel in Crowell & Moring’s Health Care Group and is part of the firm’s Digital Health Practice. With over 15 years of clinical, policy, and legal experience, Lidia provides strategic advice on health care regulatory and policy matters, with particular focus on artificial intelligence, machine learning, digital therapeutics, telehealth, interoperability, and privacy and security. Representative clients include health plans, health systems, academic medical centers, digital health companies, and long-term care facilities.

Lidia’s experience includes serving as a senior research and policy analyst at the Association of American Medical Colleges on the Policy, Strategy & Outreach team. Lidia also practiced as a nurse at Georgetown University Hospital in the general medicine with telemetry unit and the GI endoscopy suite, where she assisted with endoscopic procedures and administered conscious sedation.

Photo of Donna Reuter Donna Reuter

Leveraging her experiences as a practitioner in the healthcare industry, Donna capably serves clients with her industry experience and her commitment to achieving client goals.

Donna is a healthcare associate in the Washington D.C. office, and her practice focuses on serving healthcare payer,

Leveraging her experiences as a practitioner in the healthcare industry, Donna capably serves clients with her industry experience and her commitment to achieving client goals.

Donna is a healthcare associate in the Washington D.C. office, and her practice focuses on serving healthcare payer, provider, association, and industry clients in a broad array of legal matters spanning both litigation and regulatory compliance. She has previously worked on a variety of disputes involving areas of ERISA; medical malpractice; COVID-19; fraud, waste and abuse; intellectual property; and more.

Donna draws from her prior career as a pharmacist to inform her practice of the law: as a pharmacy manager for a major retail chain, and later as a clinical review pharmacist for a nationwide pharmacy benefit manager in Minnesota. She understands claims adjudication and billing processes, the pharmacy distribution chain, formulary management and utilization review processes, controlled substances laws, and pharmaceutical and healthcare adjacent areas.

In addition to her dedication to pro bono work, Donna enjoys mentoring, and is co-chair of the Minnesota Chapter of the Federal Bar Association’s quarterly newsletter, Bar Talk.

Photo of Tai Williams Tai Williams

As a member of Crowell’s International Dispute Resolution Practice, Tai represents foreign and domestic clients in Foreign Sovereign Immunities Act (FSIA) and Anti-Terrorism Act (ATA) litigation, which includes victims of terrorism around the globe. Further, she counsels foreign and domestic entities in disputes

As a member of Crowell’s International Dispute Resolution Practice, Tai represents foreign and domestic clients in Foreign Sovereign Immunities Act (FSIA) and Anti-Terrorism Act (ATA) litigation, which includes victims of terrorism around the globe. Further, she counsels foreign and domestic entities in disputes that may arise with foreign sovereigns.

Tai is also a member of the Health Care Group, representing managed care organizations, insurers, and health care providers in complex litigation. Her experience includes affirmative claims for recovery in commercial arbitrations based on fraudulent pricing. She works with various health care entities seeking to comply with federal and state laws and regulations, including those related to fraud and abuse.

Tai maintains an active pro bono immigration practice. She represents clients seeking asylum and special immigrant juvenile status, among other forms of relief.

Tai received her J.D. from the George Washington University Law School. During her time there, she served as a writing fellow to assist peers in their legal writing, led the GW Law Association for Women as president, and represented low-income clients as a student attorney in the Public Justice Advocacy Clinic.